A catastrophic few months, but a glimmer of hope for Immunodiagnostic Systems Holdings (AIM: IDH)?
Immunodiagnostic Systems (IDS) is engaged in the research and development of medical diagnostics as well as the manufacture and distribution of diagnostic products. The Group supply specialist immunoassay kits and automated immune analyser technologies for use in research, medical and pharmaceutical applications.
Founded in 1977, initially the Group specialised in calcium metabolism, bone disease and Vitamin D detection, and their high margin manual tests brought in a nice amount of cash. The company listed on AIM in 2004 at 51p per share, and by 2010 shares were valued at 800p. They grew both organically and via acquisitions to expand their offering, which initially helped to drive up sales and made for a successful company. In 2009 they launched their fully automated immunoanalyser, the IDS-iSYS which they hoped would help them to expand into larger markets. However the automated system was not the…